Dalteparin in Preventing DVT in Participants With Cancer
Status:
Completed
Trial end date:
2020-06-19
Target enrollment:
Participant gender:
Summary
This trial studies how well dalteparin works in preventing deep vein thrombosis (DVT) (blood
clots) in participants with cancer. Dalteparin is a blood thinner that can treat blood clots
and may prevent them from forming.